These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 31377895)
21. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Sokol ER; Karram MM Menopause; 2016 Oct; 23(10):1102-7. PubMed ID: 27404032 [TBL] [Abstract][Full Text] [Related]
22. Vulvovaginal atrophy of menopause and its impact on sexual function in an Italian clinical cohort of post-menopausal women. Nappi RE; Guida M; Marchesoni D; Cianci A; Pellegrino A; Remorgida V; Di Paolantonio T; Benedetti Panici P; J Obstet Gynaecol; 2021 Feb; 41(2):290-297. PubMed ID: 33432869 [TBL] [Abstract][Full Text] [Related]
23. Treatment to External Labia and Vaginal Canal With CO2 Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women. Samuels JB; Garcia MA Aesthet Surg J; 2019 Jan; 39(1):83-93. PubMed ID: 29726916 [TBL] [Abstract][Full Text] [Related]
24. The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy. Salvatore S; Athanasiou S; Candiani M Curr Opin Obstet Gynecol; 2015 Dec; 27(6):504-8. PubMed ID: 26536212 [TBL] [Abstract][Full Text] [Related]
25. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial. Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047 [TBL] [Abstract][Full Text] [Related]
26. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning. Pinkerton JV; Bushmakin AG; Komm BS; Abraham L Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study. Filippini M; Luvero D; Salvatore S; Pieralli A; Montera R; Plotti F; Candiani M; Angioli R Menopause; 2020 Jan; 27(1):43-49. PubMed ID: 31794500 [TBL] [Abstract][Full Text] [Related]
28. [How I do? a treatment with fractional CO Jardin I; Louis-Vahdat C; Canlorbe G; Mergui JL; Uzan C; Azaïs H Gynecol Obstet Fertil Senol; 2018 Nov; 46(10-11):735-739. PubMed ID: 30266539 [No Abstract] [Full Text] [Related]
30. The short-term efficacy and safety of fractional CO2 laser therapy for vulvovaginal symptoms in menopause, breast cancer, and lichen sclerosus. Gardner AN; Aschkenazi SO Menopause; 2021 Jan; 28(5):511-516. PubMed ID: 33399322 [TBL] [Abstract][Full Text] [Related]
31. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis. Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378 [TBL] [Abstract][Full Text] [Related]
32. Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up. Veron L; Wehrer D; Annerose-Zéphir G; Suciu V; Delaloge S; Pistilli B; Chaltiel D; Pautier P Breast Cancer Res Treat; 2021 Jul; 188(2):501-509. PubMed ID: 33891298 [TBL] [Abstract][Full Text] [Related]
33. Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: A valid therapeutic choice? A systematic review. D'Oria O; Giannini A; Buzzaccarini G; Tinelli A; Corrado G; Frega A; Vizza E; Caserta D Eur J Obstet Gynecol Reprod Biol; 2022 Oct; 277():84-89. PubMed ID: 36037664 [TBL] [Abstract][Full Text] [Related]
34. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM). Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731 [TBL] [Abstract][Full Text] [Related]
35. Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study. Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; Giuliano M; Lauria R; De Santo I; Conforti A; Gallo A; Nazzaro G; De Placido S; Locci M; De Placido G Menopause; 2018 Jun; 25(6):657-662. PubMed ID: 29286986 [TBL] [Abstract][Full Text] [Related]
36. Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy. Labrie F; Derogatis L; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; Beauregard A; Martel C; Vaillancourt M; Balser J; Moyneur É; J Sex Med; 2015 Dec; 12(12):2401-12. PubMed ID: 26597311 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women. Nappi RE; Kotek M; Brešt'anský A; Giordan N; Tramentozzi E Climacteric; 2020 Oct; 23(5):519-524. PubMed ID: 32396754 [No Abstract] [Full Text] [Related]
38. Efficacy of CO Liu M; Li F; Zhou Y; Cao Y; Li S; Li Q Int J Gynaecol Obstet; 2022 Aug; 158(2):241-251. PubMed ID: 34625949 [TBL] [Abstract][Full Text] [Related]
39. A medical device containing purified bovine colostrum (Monurelle Biogel) in the treatment of vulvovaginal atrophy in postmenopausal women: Retrospective analysis of urinary symptoms, sexual function, and quality of life. Schiavi MC; Di Tucci C; Colagiovanni V; Faiano P; Giannini A; D'Oria O; Prata G; Perniola G; Monti M; Zullo MA; Muzii L; Benedetti Panici P Low Urin Tract Symptoms; 2019 Apr; 11(2):O11-O15. PubMed ID: 29057583 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness of CO Angioli R; Stefano S; Filippini M; Pieralli A; Montera R; Plotti F; Gatti A; Bartolone M; Luvero D Int J Gynecol Cancer; 2020 May; 30(5):590-595. PubMed ID: 32221022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]